3 Dividend Stocks With a Deadline Today. Miss It and You Miss the Check

Three stocks—U.S. Global Investors, Riverview Bancorp and CF Bankshares—go ex-dividend October 9, 2026; investors had to buy by the October 8 close to qualify for the next payments. Annualized yields are about 3.1%, 1.4% and 1.1%, respectively, and the article says current earnings cover all three dividends. Risks differ: Riverview cut its quarterly payout from $0.06 to $0.02 in 2024 as classified assets more than doubled to $29.9 million, while CF Bankshares missed first-quarter EPS estimates and reported a 2.69% net interest margin.

Analysis

The ex-date is a cash-flow calendar event, not an exploitable catalyst: the expected price adjustment generally offsets the distribution, while transaction costs and small-cap liquidity can make a one-day capture worse. The actionable distinction is durability. For GROW, a cash reserve can bridge weak periods but does not replace recurring fee income; a market drawdown or outflows could pressure both earnings and the payout. For the banks, dividend coverage today is less informative than credit costs and deposit funding over the next few quarters. RVSB’s prior cut makes asset quality the key asymmetry: further classified-asset migration could erase the apparent coverage cushion. CFBK’s loan growth is supportive only if it earns an adequate spread; its relatively thin NIM and revenue miss warrant checking deposit costs and subsequent margin trends before treating the dividend growth record as durable.

Over days, expect mostly mechanical ex-date trading rather than a fundamental repricing. Over 1–3 months, monitor bank credit migration, deposit costs, and net interest margins, plus GROW’s AUM and fee revenue. Over 6–18 months, sustained credit deterioration or market-driven AUM contraction could force payout reassessment. The contrarian point is that a low payout ratio alone does not make CFBK cheap or safe after a sharp rally, and GROW’s cash balance should not be mistaken for recurring coverage. No dividend-capture trade is justified on the supplied evidence.

Key Decisions for Investors

• Do not buy any of the three solely to collect the upcoming distribution; the ex-date price adjustment is likely to absorb much of the cash benefit. For existing holders, the payment date alone is not a reason to trade.
• Treat CFBK as the relative-quality watch, not an automatic long: verify next-quarter NIM, deposit costs, credit performance, and revenue trajectory. A continued margin decline or weaker credit trend would falsify the constructive view.
• Keep RVSB on a credit-risk watch rather than reaching for its payout. Reassess if classified assets or non-performing loans rise further, or if earnings no longer cover the distribution; improvement in those measures would weaken the cautious thesis.
• For GROW, track AUM, fee revenue, and EPS across a market pullback. AUM contraction paired with declining earnings would show that cash reserves are buffering—not solving—the underlying payout risk.